In the US, Inflectra (infliximab systemic) is a member of the drug class TNF alfa inhibitors and is used to treat Ankylosing Spondylitis, Crohn's Disease, Crohn's Disease - Maintenance, Plaque Psoriasis, Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis and Ulcerative Colitis.
Ingredient matches for Inflectra
Infliximab is reported as an ingredient of Inflectra in the following countries:
- Bosnia & Herzegowina
- Croatia (Hrvatska)
- United Kingdom
- United States